1. 1288PSafety and efficacy of anti-PD-1 inhibitor ABBV-181 in lung and head and neck carcinoma. (1st October 2019) Authors: Italiano, A; Cassier, P; Roda, D; Lin, C-C; Peltola, K; Gazzah, A; Shiah, H-S; Calvo, E; Tosi, D; Gao, B; warburton, L; Tanner, M; Englert, S; Lambert, S; Parikh, A; Afar, D; Vosganian, G; Moreno, V Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 438PSafety and efficacy of the PD-1 inhibitor ABBV-181 in patients with advanced solid tumors: Preliminary phase I results from study M15-891. (23rd October 2018) Authors: Powderly, J; Cassier, P A; Cervantes, A; Gao, B; Gazzah, A; Italiano, A; Lin, C-C; Luke, J J; Moreno, V; Peltola, K; Rasco, D; Spira, A I; Tanner, M M E; Tosi, D; Afar, D; Englert, S; Parikh, A; Reddy, A; Vosganian, G; Tolcher, A W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗